Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

March 01, 1991; Volume 256,Issue 3
  • You have access
    Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens.
    K M Forsyth, R A Bjur and D P Westfall
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 821-826;
  • You have access
    Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
    B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;
  • You have access
    Neurohormonal regulation of ion transport in the porcine distal jejunum. Enhancement of sodium and chloride absorption by submucosal opiate receptors.
    F L Quito and D R Brown
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 833-840;
  • You have access
    Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis.
    J Yoo, D Schlondorff and J Neugarten
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 841-844;
  • You have access
    Separate neural mechanisms mediate sufentanil-induced pupillary responses in the cat.
    L G Sharpe
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 845-849;
  • You have access
    Caffeine potentiates vasodilator-induced renin release.
    S P Tofovic, K R Branch, R D Oliver, W D Magee and E K Jackson
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 850-860;
  • You have access
    9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
    A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;
  • You have access
    The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum.
    E Okabe, K Kuse, T Sekishita, N Suyama, K Tanaka and H Ito
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 868-875;
  • You have access
    Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;
  • You have access
    Hydroxylation of pentamidine by rat liver microsomes.
    B J Berger, V V Reddy, S T Le, R J Lombardy, J E Hall and R R Tidwell
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 883-889;
  • You have access
    Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.
    K S Arts, B B Holmes and J M Fujimoto
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 890-896;
  • You have access
    Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortex in vitro.
    E Richelson, A Nelson and R Neeper
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 897-901;
  • You have access
    Pharmacologic characterization of GABAA/benzodiazepine receptor in rat hippocampus during aging.
    D Ruano, J Cano, A Machado and J Vitorica
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 902-908;
  • You have access
    Antagonism of morphine antinociception by intrathecally administered corticotropin-releasing factor in mice.
    Z H Song and A E Takemori
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 909-912;
  • You have access
    Isovolumic hemodilution with dextran 40 in the rat: effect on the development of peripheral edema and various physiologic parameters.
    A D Perez-Trepichio, A V Salgado and S C Jones
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 913-916;
  • You have access
    Mechanism of pH amelioration of 2-bromohydroquinone-induced toxicity to rabbit renal proximal tubules.
    D P Rodeheaver and R G Schnellmann
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 917-921;
  • You have access
    Ex vivo binding of t-[35S )butylbicyclophosphorothionate: a biochemical tool to study the pharmacology of ethanol at the gamma-aminobutyric acid-coupled chloride channel.
    E Sanna, A Concas, M Serra, G Santoro and G Biggio
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 922-928;
  • You have access
    5-lipoxygenase inhibitory activity of zileuton.
    G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;
  • You have access
    Comparison of [3H]ryanodine receptors and Ca++ release from rat cardiac and rabbit skeletal muscle sarcoplasmic reticulum.
    I Zimányi and I N Pessah
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 938-946;
  • You have access
    Effect of alcohols and other hypnotics in mice selected for differential sensitivity to hypothermic actions of ethanol.
    D J Feller and J C Crabbe
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 947-953;
  • You have access
    Effect of neurotransmitter-selective drugs in mice selected for differential sensitivity to the hypothermic actions of ethanol.
    D J Feller and J C Crabbe
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 954-958;
  • You have access
    Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.
    R E Jonkers, R P Koopmans, E J Portier and C J van Boxtel
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 959-966;
  • You have access
    Effect of reserpine on histamine metabolism in the mouse brain.
    N Muroi, R Oishi and K Saeki
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 967-972;
  • You have access
    5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    M J Millan, K Bervoets and F C Colpaert
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 973-982;
  • You have access
    5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
    M J Millan and F C Colpaert
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 983-992;
  • You have access
    5-hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats.
    M J Millan and F C Colpaert
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 993-1001;
  • You have access
    Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
    A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;
  • You have access
    Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets.
    S C Pandey, J M Davis, D W Schwertz and G N Pandey
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1010-1018;
  • You have access
    Antagonism of calcitonin gene-related peptide (CGRP) by human CGRP-(8-37): role of CGRP in internal anal sphincter relaxation.
    S Chakder and S Rattan
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1019-1024;
  • You have access
    Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
    E Edwards, K Harkins, C R Ashby and R Y Wang
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1025-1032;
  • You have access
    Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.
    T L Yaksh, M B Sabbe, D Lucas, E Mjanger and R E Chipkin
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1033-1041;
  • You have access
    Leukotriene C4 binds to receptors and has positive inotropic effects in bullfrog heart.
    M Chiono, R S Heller, J J Andazola and C A Herman
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1042-1048;
  • You have access
    SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    A C Le Monnier de Gouville, K Lawson, C Thiry and I Cavero
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1049-1056;
  • You have access
    Stimulation of gastric bicarbonate secretion by an analog of thyrotropin-releasing hormone, YM-14673, in the rat.
    K Takeuchi, K Ueshima and S Okabe
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1057-1062;
  • You have access
    Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies.
    J P Bourreau, Z D Zhang, A M Low, C Y Kwan and E E Daniel
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1063-1071;
  • You have access
    Block of Na+ channels by imipramine in guinea-pig cardiac ventricular cells.
    Y Habuchi, T Furukawa, H Tanaka, Y Tsujimura and M Yoshimura
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1072-1081;
  • You have access
    Toluene diisocyanate contracts guinea pig bronchial smooth muscle by activating capsaicin-sensitive sensory nerves.
    C E Mapp, P D Graf, A Boniotti and J A Nadel
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1082-1085;
  • You have access
    Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring.
    T J Cicero, M L Adams, A Giordano, B T Miller, L O'Connor and B Nock
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1086-1093;
  • You have access
    Involvement of sodium in the protective effect of 5-(N,N-dimethyl)-amiloride on ischemia-reperfusion injury in isolated rat ventricular wall.
    H Meng and G N Pierce
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1094-1100;
  • You have access
    Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.
    T S Shippenberg and A Herz
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1101-1106;
  • You have access
    The transport of digoxin across the perfused human placental lobule.
    L O Derewlany, J S Leeder, R Kumar, I C Radde, B Knie and G Koren
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1107-1111;
  • You have access
    Passive permeability of salicylic acid in renal proximal S2 and S3 tubules.
    J Y Chatton and F Roch-Ramel
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1112-1118;
  • You have access
    Electrophysiologic studies on the spinal antinociceptive action of kappa opioid agonists in the adult and 21-day-old rat.
    A F Sullivan and A H Dickenson
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1119-1125;
  • You have access
    Neural activation of alpha-2 adrenoceptors in cat cutaneous vasculature.
    M C Koss, M Kawarai and T Ito
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1126-1131;
  • You have access
    High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport.
    G Lonart and M J Zigmond
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1132-1138;
  • You have access
    The role of prostaglandin synthetase in the rate depressant effects and narcosis caused by ethanol.
    G I Elmer and F R George
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1139-1146;
  • You have access
    Cardiovascular and sympathetic effects of injecting serotonin into the nucleus tractus solitarius in rats.
    H Itoh and R D Buñag
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1147-1153;
  • You have access
    gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
    M Massotti, J L Schlichting, M D Antonacci, P Giusti, M Memo, E Costa and A Guidotti
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1154-1160;
  • You have access
    Characterization of spermidine-dependent [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) binding in brain synaptic membranes treated with Triton X-100.
    Y Yoneda, K Ogita and R Enomoto
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1161-1172;
  • You have access
    N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    T D Smith, S J Annis, F J Ehlert and F M Leslie
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1173-1181;
  • You have access
    Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins.
    C E Thomas and R L Jackson
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1182-1188;
  • You have access
    Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples.
    F P Guengerich and C G Turvy
    Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1189-1194;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 256, Issue 3
1 Mar 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics